To support the notion that forskolin can be of potential use in MM therapy, CD138+ B cells isolated from ten patients with MM were co-cultured with bone marrow stromal cells and treated with forskolin in combination with melphalan, cyclophosphamide, bortezomib or dexamethasone, respectively. Here, SDC1 is linked to Miyoshi myopathy.